Wegovy & Mounjaro are medications used in the treatment of type 2 diabetes and obesity. It belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Wegovy & Mounjaro work by mimicking the actions of the naturally occurring hormone glucagon-like peptide-1 (GLP-1) in the body.

Here’s how Wegovy & Mounjaro work:

1. **Stimulation of Insulin Release**: GLP-1s stimulate the release of insulin from the pancreas in response to elevated blood sugar levels. Insulin helps to lower blood sugar levels by facilitating the uptake of glucose by cells, particularly in muscles and the liver.

2. **Inhibition of Glucagon Release**: Glucagon is a hormone produced by the pancreas that raises blood sugar levels by promoting the release of glucose from the liver. GLP-1s help inhibit the release of glucagon, thereby reducing the amount of glucose released into the bloodstream.

3. **Slowing Gastric Emptying**: GLP-1s slows down the rate at which food moves through the stomach and into the small intestine. This delay in gastric emptying helps to reduce the rapid rise in blood sugar levels that typically occurs after eating.

4. **Promotion of Satiety**: GLP-1s  can also act on the brain to reduce appetite, leading to decreased food intake and potential weight loss. This effect is particularly beneficial for individuals with type 2 diabetes who are overweight or obese.

By combining these effects—stimulating insulin release, inhibiting glucagon release, slowing gastric emptying, and promoting satiety—GLP-1s help to improve glycemic control, reduce blood sugar levels, and potentially aid in weight loss in people with type 2 diabetes and obesity. It is typically administered as a subcutaneous injection and is used in conjunction with diet and exercise to effectively manage these conditions.

GLP-1s, like any medication, can cause side effects in some individuals. Common side effects of GLP-1s may include:

1. **Nausea**: Nausea is one of the most common side effects reported with GLP-1 use, especially when initiating treatment. This symptom may improve over time for some individuals.

2. **Vomiting**: Some people may experience vomiting as a side effect of GLP-1s, particularly during the initial stages of treatment.

3. **Diarrhea**: Diarrhea is another gastrointestinal side effect that may occur with GLP-1 use. It may resolve on its own or with adjustments in dosage.

4. **Constipation**: While less common than diarrhea, some individuals may experience constipation as a side effect of GLP-1 use.

5. **Abdominal Pain**: Pain or discomfort in the abdominal region is another potential side effect of GLP-1s.

6. **Hypoglycemia**:  GLP-1 receptor agonists, can lower blood sugar levels. In some cases, this may lead to hypoglycemia (low blood sugar), especially when used in combination with other medications that lower blood sugar levels.

7. **Injection Site Reactions**: GLP-1 medications are administered as a subcutaneous injection, which can sometimes cause injection site reactions such as redness, swelling, or itching.

8. **Pancreatitis**: Rarely, GLP-1s may increase the risk of pancreatitis, an inflammation of the pancreas. Symptoms of pancreatitis include severe abdominal pain, nausea, and vomiting. If these symptoms occur, medical attention should be sought immediately.

9. **Thyroid Tumors**: There have been reports of thyroid tumors, including thyroid cancer, in animal studies with GLP-1s. However, it is not clear if the same risk exists in humans.

It’s important to note that not everyone will experience these side effects, and some individuals may experience different or no side effects at all. Additionally, if you experience any concerning or severe side effects while taking any GLP-1, it is essential to consult your healthcare provider for guidance. They can provide personalized advice and may adjust your treatment regimen if necessary.